Photo taken from Asaf Zviran/LinkedIn
Oct 5, 2023, 17:19
Asaf Zviran: Next generation AI-powered spectral proteomics is coming… Vionix Biosciences!
Asaf Zviran, Co-Founder and CTO of Vionix Biosciences, recently shared on LinkedIn:
“Coming out of stealth!
Next Generation Sequencing (NGS) has transformed medicine and increased our understanding of human diseases. However, there is a growing need for: rapid (<1h), cheap (<$50) and point-of-care diagnostic solutions. Coupled with comprehensive proteomics / metabolomics characterization. With clinical applications spanning from infectious diseases (e.g., tuberculosis) to cancer screening and aging, using a simple breath or urine test.
Next generation AI-powered spectral proteomics is coming… Vionix Biosciences!
Check out our recent coverage at Bloomberg.
Stay tuned for more news…”
For details click here.
Source: Asaf Zviran/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12